The share of U.S. scientific publications in endocrinology, diabetes, and metabolism among the world's top 10% cited publications is forecasted to show a gradual decline from 2024 to 2028. The value starts at 12.24 in 2024, decreasing year-on-year by approximately 1.23% to 11.63% by 2028. Compared to 2023, when the share was higher, the cumulative annual growth rate (CAGR) over this 5-year period suggests a consistent drop across these fields. This trend could indicate increasing global competition or shifting research focus away from these areas in the U.S.
Future trends to monitor include potential increases in collaborative international research efforts and funding allocations, which may alter these projections. Additionally, technological advancements or breakthroughs in related fields could influence publication impacts and trends significantly.
